SCHEMBL4615784

SCHEMBL4615784

Cc1cc(Oc2cccc(C#N)c2)ccc1OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 4/20 0.56
MAOB P27338 3/20 0.51
FFAR4 Q5NUL3 3/20 0.51
FFAR1 O14842 3/20 0.51
GPR34 Q9UPC5 1/20 0.46
PPARG P37231 1/20 0.45
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
HTR6 P50406 2/20 0.42
AR P10275 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4613874 0.80 MRGPRX4 (0.65) MRGPRX4MAOBFFAR4FFAR1
SCHEMBL30344886 0.79 MAOB (0.69) MAOBFFAR4FFAR1GPR34SMN1; SMN2
SCHEMBL538272 0.79 MAOB (0.69) MAOBFFAR4FFAR1GPR34SMN1; SMN2
SCHEMBL1439758 0.78 PPARD (0.58) MRGPRX4MAOBFFAR4FFAR1PPARG
SCHEMBL1437459 0.78 MAOB (0.52) MRGPRX4MAOBFFAR4FFAR1PPARG
SCHEMBL70797 0.77 MAOB (0.60) MRGPRX4MAOBMAPTMAPK1TDP1
SCHEMBL18165808 0.76 PDE4A (0.48) PPARGMAPTL3MBTL1SMN1; SMN2AR
SCHEMBL1437002 0.75 MAOB (0.56) MRGPRX4MAOBFFAR4FFAR1PPARG
SCHEMBL1248693 0.75 MAOB (0.66) MRGPRX4MAOBFFAR4FFAR1GPR34
SCHEMBL3758682 0.74 MAOB (0.61) MRGPRX4MAOBFFAR1SMN1; SMN2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
EP-1697304-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005054176-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD MRGPRX4 1752/4885MAOB 4323/4885FFAR4 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.